Titration is the whole game
Why the ramp schedule your physician sets matters more than the molecule you started with, and how side effects usually trace back to pace.
Read articleAdvertising restrictions on health claims mean we grow through education first. Everything here is reviewed by our clinical team before publishing.
Why the ramp schedule your physician sets matters more than the molecule you started with, and how side effects usually trace back to pace.
Read articleA plain-language look at the regulatory gap gray-market sellers operate in, and what a prescription actually changes for the patient.
Read articleWhat a baseline growth-factor panel tells your physician before a secretagogue protocol is written — and what it doesn't.
Read articleThe state of the evidence, what patients report, and why we won't publish before-and-after photos.
Read articleWe filmed a full intake review with a prescriber, minus the patient details. Here's what they look for first.
Read articleGHK-Cu shows up in every skincare line. What a compounded, prescribed formulation does differently.
Read articleNo hype, no dosing advice — just what our physicians are reading and why.
Start intake instead